"10.1371_journal.pone.0088517","plos one","2014-02-26T00:00:00Z","Jonathan C√¥t√©; Yvette Bonvalot; Ga√©tan Carrier; Caroline Lapointe; Uwe Fuhr; Dorota Tomalik-Scharte; Bertil Wachall; Mich√®le Bouchard","D√©partement de sant√© environnementale et sant√© au travail, Chaire danalyse et de gestion des risques toxicologiques and Institut de recherche en sant√© publique de lUniversit√© de Montr√©al (IRSPUM), Universit√© de Montr√©al, Montreal, Quebec, Canada; Environmental Health Program, Health Canada, Longueuil, Quebec, Canada; Department of Pharmacology, University of Cologne, Clinical Pharmacology Unit, K√∂ln, Germany; Infectopharm Arzneimittel und Consilium GmbH, Heppenheim, Germany","Conceived and designed the experiments: MB GC. Performed the experiments: JC MB. Analyzed the data: MB JC. Contributed reagents/materials/analysis tools: MB JC YB CL UF DTS BW. Wrote the paper: JC MB.","An employee from Infectopharm is a co-author on this manuscript, we declare that the company has had no involvement in model development or use of the model. The company has not provided any funding or consultant fees for this work. The company only provided the raw data allowing the validation of the model. The company has no patent or access to the model or its interpretation. Only the University of Montreal and Health Canada members have the PI on the modeling. Therefore, we declare that this does not alter our adherence to all the PLOS ONE policies on sharing data and materials.","2014","02","Jonathan C√¥t√©","JC√√",8,TRUE,2,2,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
